Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 192

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Prescription opioid analgesic use in France: Trends and impact on morbidity–mortality

Chenaf, C., Kaboré, J.‐L., Delorme, J., Pereira, B., Mulliez, A., Zenut, M., Delage, N., Ardid, D., Eschalier, A., Authier, N. · 2019 · European Journal of Pain

Abstract

Background: While data from USA and Canada demonstrate an opioid overdose epidemic, very little nation‐wide European studies have been published on this topical subject. Methods: Using a nationally representative sample of the French Claims database (>700,000 patients), the exhaustive nationwide hospital discharge database, and national mortality registry, all patients dispensed at least one prescription opioid ( PO ) in 2004–2017 were identified, to describe trends in PO analgesic use, shopping behaviour, opioid‐related hospitalizations and deaths. Annual prevalence of PO use and shopping behaviour (≥1 day of overlapping prescriptions from ≥2 prescribers, dispensed by ≥3 pharmacies) was estimated. Results: In 2004–2017, the annual prevalence of weak opioid use codeine, tramadol and opium rose by 150%, 123%, and 244%, respectively ( p < 0.05). Strong opioid use increased from 0.54% to 1.1% (+104%, p < 0.05), significantly for oxycodone (+1950%). Strong opioid use in chronic noncancer pain rose by 88% ( p < 0.05) and 1180% for oxycodone. Opioid shopping increased from 0.50% to 0.67% (+34%, p < 0.05), associated with higher mortality risk HR = 2.8 [95% confidence interval ( CI ): 1.2–6.4]. Opioid‐related hospitalizations increased from 15 to 40 per 1,000,000 population (+167%, 2000–2017), and opioid‐related deaths from 1.3 to 3.2 per 1,000,000 population (+146%, 2000–2015). Conclusions: This study provided a first European approach to a nationwide estimation with complete access to several national registries. In 2004–2017 in France, PO use excluding dextropropoxyphene more than doubled. The increase in oxycodone and fentanyl use, and nontrivial increasing trend in opioid‐related morbidity–mortality should prompt authorities to closely monitor PO consumption in order to prevent alarming increases in opioid‐related morbidity–mortality. Significance: In 2004–2017, prescription opioid use in France at least doubled and oxycodone use increased particularly, associated with a nontrivial increase in opioid‐related morbidity–mortality. Although giving no indication for an ‘opioid epidemic,’ these findings call for proper monitoring of opioid use.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ejp.1291

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 192

Metadata

Authors
Chenaf, C., Kaboré, J. ‐., Delorme, J., Pereira, B., Mulliez, A., Zenut, M., Delage, N., Ardid, D., Eschalier, A., & Authier, N.
Venue
European Journal of Pain
Publisher
Wiley
Published
2018-08-20
Volume
23
Issue
1
Pages
124-134
ISSN
  • 1090-3801 (ISSN-L)
  • 1532-2149
OpenAlex
W2883783530
Cited by
192
References
5
FWCI
21.36
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prescription opioid analgesic use in France: Trends and impact on morbidity–mortality. https://app.cochat.ai/papers/10.1002/ejp.1291
The paper
Chenaf, C., Kaboré, J. ‐., Delorme, J., Pereira, B., Mulliez, A., Zenut, M., Delage, N., Ardid, D., Eschalier, A., & Authier, N. (2019). Prescription opioid analgesic use in France: Trends and impact on morbidity–mortality. European Journal of Pain. https://doi.org/10.1002/ejp.1291

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.